Introduction of Human Recombinant Angiogenin at the Early Stages of Postnatal Development Inhibits the Growth of Mice |
| |
| Authors: | Mertvetsov N P Voitenko N N Dudarev A N Ivanova E A Khaidarova N V Popova N K Tarantul V Z |
| |
| Institution: | (1) Siberian Branch of the Russian Academy of Medical Sciences, Institute of Molecular Biology and Biophysics, ul. Timakova 2, Novosibirsk, 630017, Russia;(2) Russian Academy of Sciences, Institute of Cytology and Genetics, pr. Akademika Lavrent'eva 10, Novosibirsk, 630090, Russia;(3) Russian Academy of Sciences, Institute of Molecular Genetics, pl. Akademika Kurchatova 46, Moscow, 123182, Russia |
| |
| Abstract: | We studied the influence of recombinant DNA containing the cloned angiogenin gene, plasmid DNA without angiogenin gene, and purified recombinant angiogenin injected to Tg8 mice at the age of two days on the body mass of 28- and 40-day old mice. The body mass of mice that were injected with the cloned angiogenin gene or purified angiogenin was less than in the control mice. The body mice of Tg8 mice injected with recombinant DNA containing the cloned angiogenin gene did not increase from day 28 to day 40, while in the mice with purified recombinant angiogenin and control mice it increased by 24 and 57%, respectively. These data suggest that the elevated level of angiogenin at the early developmental stages inhibits the increase of body mass. The effect we described is related, in al likelihood, to the known inhibitory effect of angiogenin on protein synthesis. |
| |
| Keywords: | mice growth early postnatal development recombinant DNA containing cloned angiogenin gene plasmid DNA without angiogenin gene purified recombinant angiogenin |
| 本文献已被 SpringerLink 等数据库收录！ |
|
